Biotech's Boom Suffers a Setback in March April 01, 2014 | Press Release

Investors Flock to Biotech March 03, 2014 | Press Release

Biotech IPOs Off to a Strong Start in 2014 February 03, 2014 | Press Release

  See all News
Sign up for a free subscription to The Burrill Weekly Brief 
Sign up to receive email notifications about our upcoming events and news.

All News

Biotech's Boom Suffers a Setback in March

While Investors Develop Jitters, Life Sciences Companies Rake in Record Capital, says Burrill Media

April 01, 2014

› Learn more


Biotech IPOs Off to a Strong Start in 2014

Sector shines in public markets while general indices surge, Burrill & Company says

February 03, 2014

› Learn more


Biotech Stocks Win Big in 2013

Sector rides the crest of a spectacular year for Wall Street, Burrill & Company says

January 01, 2014

› Learn more


Biotech Visionary G. Steven Burrill Offers Predictions for 2014

Sees sector maintaining momentum in the new year, but at a slower pace as valuations return to normal

December 16, 2013

› Learn more


Life Sciences IPOs Take a Breather

Frenzy cools as investors seeking a quick return turn elsewhere, Burrill & Company says

December 02, 2013

› Learn more


U.S. Supreme Court Upholds Healthcare Reform

Individual Mandate Ruled Constitutional as a Tax

June 28, 2012

› Learn more


Debt Worries, Political Dysfunction Take a Toll on Biotech in Third Quarter

Biotech stocks fall with the market as financing activity slows

October 03, 2011

› Learn more


Promise of Personalized Medicine Remains Unrealized

Burrill & Company Meeting Explores the Challenges Faced by the Drugs, Tools, and Diagnostics Companies Leading a Revolution in Healthcare

September 15, 2011

› Learn more


Volatile Markets in August Take a Toll on Life Sciences IPOs

Burrill & Company says poor performance for new issues, depressed stocks, could fuel surge in M&A

August 31, 2011

› Learn more


New Drug Approvals in 2011 Already Match 2010 Total

Burrill & Company sees environment improving for life sciences, but macroeconomic threats persist.

July 31, 2011

› Learn more


M&A Has Failed to Build Value for Pharma, Burrill Annual Biotech Report Finds

Pressure to Find Better Models to Discover and Develop New Drugs Increases

April 12, 2011

› Learn more


Boom Times for Genomics Startups

Investment is picking up as sales of gene sequencing machines surge

March 17, 2011

› Learn more


Dirk Lammerts joins Burrill Venture Capital Group

Focus will be on building the company’s activities in digital health

March 10, 2011

› Learn more


Biotech posts strong first quarter gain

Industry benefits from healthcare reform and robust general markets

April 01, 2010

› Learn more


Burrill & Company and WR Hambrecht + Co to collaborate on OpenIPO® transactions

Joint venture will focus on select healthcare companies

October 09, 2009

› Learn more

News Archive: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | View All